Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Abiomed Inc
(NQ:
ABMD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 21, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Abiomed Inc
< Previous
1
2
Next >
World’s First Patient Implanted with Impella BTR Minimally Invasive Heart Pump
April 26, 2022
From
Abiomed
Via
Business Wire
Abiomed Fourth Quarter Fiscal 2022 Earnings and Conference Call Notification
April 08, 2022
From
Abiomed, Inc.
Via
Business Wire
First Patient in Japan Treated with Impella 5.5 with SmartAssist
April 06, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed to Host Investor Call on Impella ECP, the World’s Smallest Heart Pump at 9 French
March 21, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed to Present at the SVB Leerink 11th Annual Global Healthcare Conference
February 08, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed Announces Record Revenue of $261 Million, up 13% Year Over Year
February 03, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed Third Quarter Fiscal 2022 Earnings and Conference Call Notification
January 14, 2022
From
Abiomed, Inc.
Via
Business Wire
Early Feasibility Study Demonstrates Successful Use of Abiomed’s preCARDIA Technology
January 12, 2022
From
Abiomed, Inc.
Via
Business Wire
Regulators Approve Impella 5.5 With SmartAssist in Japan and Hong Kong; US FDA Grants Impella BTR Conditional IDE Approval for First-in-Human Early Feasibility Study
January 10, 2022
From
Abiomed, Inc.
Via
Business Wire
Abiomed to Present at the 40th Annual J.P. Morgan Healthcare Conference
December 29, 2021
From
Abiomed, Inc.
Via
Business Wire
Abiomed to Present at Upcoming Investor Conferences
November 18, 2021
From
Abiomed, Inc.
Via
Business Wire
Two Large Studies Demonstrate Complete Revascularization with Impella Heart Pumps Improves Ejection Fraction and Long-Term Patient Outcomes
November 04, 2021
From
Abiomed, Inc.
Via
Business Wire
Impella Advances to Higher Level of Recommendation in Newest ESC Guidelines
November 03, 2021
From
Abiomed, Inc.
Via
Business Wire
TCT 2021 to Highlight Improved Patient Outcomes with Impella’s Small, Smart and Connected Technology
November 01, 2021
From
Abiomed, Inc.
Via
Business Wire
Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year
October 28, 2021
From
Abiomed, Inc.
Via
Business Wire
Abiomed Second Quarter Fiscal 2022 Earnings and Conference Call Notification
October 07, 2021
From
Abiomed, Inc.
Via
Business Wire
FDA Grants Breakthrough Device Designation to Impella ECP, the World’s Smallest Heart Pump
August 18, 2021
From
Abiomed
Via
Business Wire
Abiomed Announces Record Revenue of $253 Million, Up 53% Year Over Year
August 04, 2021
From
Abiomed, Inc.
Via
Business Wire
Abiomed First Quarter Fiscal 2022 Earnings and Conference Call Notification
July 15, 2021
From
Abiomed, Inc.
Via
Business Wire
FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure
June 29, 2021
From
Abiomed, Inc.
Via
Business Wire
Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients
June 01, 2021
From
Abiomed
Via
Business Wire
Abiomed to Present at Upcoming Investor Conferences
May 25, 2021
From
Abiomed, Inc.
Via
Business Wire
Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin
April 29, 2021
From
Abiomed, Inc.
Via
Business Wire
Final Results from the National Cardiogenic Shock Initiative (NCSI) Study Demonstrate the Benefit of Early Cardiac Unloading with Impella
April 28, 2021
From
Abiomed, Inc.
Via
Business Wire
Dr. Paula A. Johnson Joins Abiomed Board of Directors
April 28, 2021
From
Abiomed
Via
Business Wire
First Patient Enrolled in PROTECT IV Randomized Controlled Trial of Impella
April 15, 2021
From
Abiomed, Inc.
Via
Business Wire
Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification
April 08, 2021
From
Abiomed, Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.